Plasma sRAGE is independently associated with high sensitivity C-reactive protein in type 2 diabetes without coronary artery disease.
Our studies suggest that plasma soluble advanced glycation end products (sRAGEs) has significantly negative association with high sensitivity C-reactive protein (hs-CRP) in 245 type 2 diabetes patients without diagnosed coronary artery disease (CAD). sRAGE maybe act as a novel biomarker for predicting the atherosclerosis in diabetes at the early stage.
An
Xiao-Fei
XF
The Department of Endocrinology, Jiangsu Province Hospital of TCM, 155 Han-Zhong Road, Nanjing 210029, China.
Zhao
Yue
Y
Yu
Jiang-Yi
JY
Liu
Jing-Shun
JS
Gu
Wan-Jian
WJ
Gao
Feng
F
D000368:Aged; D002097:C-Reactive Protein / Q000378:metabolism*; D003324:Coronary Artery Disease / Q000097:blood* / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications; D005260:Female; D017127:Glycation End Products, Advanced / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012044:Regression Analysis
D017127:Glycation End Products, Advanced; D002097:C-Reactive Protein